Evidence map›Paper›PMID 29147652›Full record

ArticleBioMed research international2017

Identification of Potent Chloride Intracellular Channel Protein 1 Inhibitors from Traditional Chinese Medicine through Structure-Based Virtual Screening and Molecular Dynamics Analysis.

Wei Wang, Minghui Wan, Dongjiang Liao, Guilin Peng, Xin Xu, Weiqiang Yin, Guixin Guo, Funeng Jiang, Weide Zhong, Jianxing He

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Identification of Key Candidate Genes and Pathways ofIndian journal of microbiology · 2020
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Wei WangDepartment of Thoracic Surgery, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.ORCID 0000-0002-3035-6062
Minghui WanSouthern Medical University, Guangzhou 510000, China.
Dongjiang LiaoGuangzhou Institute of Respiratory Diseases and China State Key Laboratory of Respiratory Disease, Guangzhou 510120, China.
Guilin PengDepartment of Thoracic Surgery, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Xin XuDepartment of Thoracic Surgery, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Weiqiang YinDepartment of Thoracic Surgery, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Guixin GuoNational Supercomputer Center in Guangzhou, Guangzhou 510000, China.
Funeng JiangDepartment of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China.
Weide ZhongDepartment of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China.
Jianxing HeDepartment of Thoracic Surgery, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.ORCID 0000-0003-0404-8741
First Affiliated Hospital of Guangzhou Medical University · CNGuangzhou First People's Hospital · CNNational Supercomputing Center in Shenzhen · CNState Key Laboratory of Respiratory Disease · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chloride intracellular channel 1 (CLIC1) is involved in the development of most aggressive human tumors, including gastric, colon, lung, liver, and glioblastoma cancers. It has become an attractive new therapeutic target for several types of cancer. In this work, we aim to identify natural products as potent CLIC1 inhibitors from Traditional Chinese Medicine (TCM) database using structure-based virtual screening and molecular dynamics (MD) simulation. First, structure-based docking was employed to screen the refined TCM database and the top 500 TCM compounds were obtained and reranked by

Indexed as

Molecular Dynamics SimulationChloride ChannelsDrugs, Chinese HerbalHumansMedicine, Chinese TraditionalMembrane Transport ModulatorsNeoplasm ProteinsNeoplasmsChloride ChannelsCLIC1 protein, humanDrugs, Chinese HerbalMembrane Transport ModulatorsNeoplasm Proteins

Identifiers

PMID29147652
PMCPMC5632872
OpenAlexW2757556159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.